Altaroc
Newsroom
etc.
Private Equity

The very good performance of European companies backed by Private Equity funds

Published on
20/12/2023
Amended on
28/3/2024
0
minute(s)
European companies backed by Private Equity funds achieve average annual growth of 7%, twice as high as those backed by Private Equity. Gain.pro highlights opportunities in the Technology, Media, Telecommunications, Financial Services, Science, Healthcare, Industry, Materials and Energy sectors. European investors must therefore remain vigilant in their quest for growth.
By
Damien Hélène
Damien Hélène
This article has been automatically translated. Please excuse any inaccuracies or translation errors.

On average, European companies backed by Private Equity funds have seen their sales grow by 7% a year over the past 5 years. These are the findings of Gain.pro 's latest report: Finding Growth in Europe.

Their average sales growth is twice as high as that of privately-owned companies.

" With high interest rates looking set to persist, growth is only going to become more difficult. However, what we see in our data analysis is that Private Equity-owned companies continue to show resilience. It' s clear that, despite the current uninspiring macro-economic environment, investors can look forward to many significant opportunities in the European Private Equity landscape," comments Sid Jain, Director of Insights at Gain.pro, whose platform provides in-depth information on companies, investors, industries and investment activity.

What are the most promising sectors?

The Technology, Media & Telecommunications sector boasts an average organic growth rate of 8-10%, followed by Financial Services, Science and Healthcare. The report also highlights numerous growth opportunities in theindustrial, materials andenergy sectors, which have historically grown more slowly.

As Sid Jain concludes, "Ultimately, we believe that European investors need to be more vigilant in their quest for growth. They need to look for multiple arbitrage opportunities based more on a buy-and-build strategy and operational optimization, not on valuation multiple arbitrage. "

No items found.

The latest Hors-Séries

Special Summer 2024 feature

item(s)

10 revolutionary innovations you didn't know about

7
item(s)

Artificial Intelligence at the service of health

12
item(s)
Newsletter
Subscribe to our newsletter to keep up to date with all the latest news.
No items found.
Europe
Technology and Software
B2B Services
Healthcare